These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24521012)

  • 21. [Study on early change features of microRNA in the peripheral blood of Sophorae tonkinensis radix et rhizoma induced liver injury rats].
    Sheng YH; Jin RM; Yao GT; Zhou L; Qiao JY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Mar; 33(3):385-91. PubMed ID: 23713256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury.
    Yang X; Weng Z; Mendrick DL; Shi Q
    Toxicol Lett; 2014 Mar; 225(3):401-6. PubMed ID: 24462978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for drug-induced liver injury.
    Shi Q; Hong H; Senior J; Tong W
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):225-34. PubMed ID: 20350268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis method for discovering reliable biomarkers by integrating statistical and biological approaches: An application to liver toxicity.
    Cho H; Kim H; Na D; Kim SY; Jo D; Lee D
    Biochem Biophys Res Commun; 2016 Mar; 471(2):274-81. PubMed ID: 26820531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA expression profiling in cancer from a bioinformatics prospective.
    Gusev Y; Brackett DJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in Drug-induced Liver Injury.
    Li LM; Wang D; Zen K
    J Clin Transl Hepatol; 2014 Sep; 2(3):162-9. PubMed ID: 26357624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of urine proteomics for biomarker discovery in drug-induced liver injury.
    van Swelm RP; Kramers C; Masereeuw R; Russel FG
    Crit Rev Toxicol; 2014 Nov; 44(10):823-41. PubMed ID: 25264586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?
    Iruzubieta P; Arias-Loste MT; Barbier-Torres L; Martinez-Chantar ML; Crespo J
    Biomed Res Int; 2015; 2015():386186. PubMed ID: 26824035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs and drug-induced kidney injury.
    Pavkovic M; Vaidya VS
    Pharmacol Ther; 2016 Jul; 163():48-57. PubMed ID: 27126472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs as Promising Tumor Biomarkers.
    Chen M; Calin GA; Meng QH
    Adv Clin Chem; 2014; 67():189-214. PubMed ID: 25735862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ExcellmiRDB for translational genomics: a curated online resource for extracellular microRNAs.
    Barupal JK; Saini AK; Chand T; Meena A; Beniwal S; Suthar JR; Meena N; Kachhwaha S; Kothari SL
    OMICS; 2015 Jan; 19(1):24-30. PubMed ID: 25562198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous detection of multiple microRNAs for expression profiles of microRNAs in lung cancer cell lines by capillary electrophoresis with dual laser-induced fluorescence.
    Ban E; Chae DK; Song EJ
    J Chromatogr A; 2013 Nov; 1315():195-9. PubMed ID: 24094482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and regulatory application of microRNA biomarkers.
    Krauskopf J; Verheijen M; Kleinjans JC; de Kok TM; Caiment F
    Biomark Med; 2015; 9(11):1137-51. PubMed ID: 26502281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging efforts for discovering new biomarkers of liver disease and hepatotoxicity.
    Hong H; Tong W
    Biomark Med; 2014; 8(2):143-6. PubMed ID: 24521010
    [No Abstract]   [Full Text] [Related]  

  • 36. The role for microRNAs in drug toxicity and in safety assessment.
    Marrone AK; Beland FA; Pogribny IP
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):601-11. PubMed ID: 25739314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
    Beger RD; Sun J; Schnackenberg LK
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):154-66. PubMed ID: 19932708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Promising Urinary MicroRNA Biomarkers in Two Rat Models of Glomerular Injury.
    Nassirpour R; Homer BL; Mathur S; Li Y; Li Z; Brown T; Carraher D; Warneke J; Bailey S; Percival K; O'Neil SP; Whiteley LO
    Toxicol Sci; 2015 Nov; 148(1):35-47. PubMed ID: 26253709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far.
    Roma-Rodrigues C; Raposo LR; Fernandes AR
    Biomed Res Int; 2015; 2015():983290. PubMed ID: 26504850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA profiling using µParaflo microfluidic array technology.
    Zhou X; Zhu Q; Eicken C; Sheng N; Zhang X; Yang L; Gao X
    Methods Mol Biol; 2012; 822():153-82. PubMed ID: 22144198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.